Unexpected Inflammation in the Sympathetic Ganglia in Thromboangiitis Obliterans
- PMID: 29142485
- PMCID: PMC5685794
- DOI: 10.1055/s-0037-1604410
Unexpected Inflammation in the Sympathetic Ganglia in Thromboangiitis Obliterans
Abstract
The aim of this study was to inspect more closely the microscopic and molecular sympathetic ganglia histology in thromboangiitis obliterans (TAO). The paraffin block and frozen RNAlater-treated tissue of the lumbar sympathetic ganglia of 19 TAO Caucasian male patients were evaluated. The gene expression of cluster of differentiation 4 (CD4) and cluster of differentiation 8 (CD8) markers in the frozen RNAlater-treated sympathetic ganglia tissues were evaluated by real-time polymerase chain reaction. Unexpectedly, lymphocyte infiltration was observed in all of the histological sections, ranging from scattered to moderate lymphocyte infiltration. In seven patients, five of them underwent below-knee amputation, neutrophil infiltration was observed in addition to lymphocyte infiltration. The gene expression of the CD8 marker in all of the samples with the expression of CD4 markers in only four tissue samples was demonstrated. The expression of CD8 in comparison to CD4 was approximately 4.37-fold changes using Pfaffle method. It appears that inflammation of the sympathetic ganglia plays a role in the pathophysiology of TAO and its outcome. Sympathetic ganglia inflammation may be responsible for general vasoconstriction, vascular inflammation, and the increased risk of thrombotic events, by activating the platelets. The dominant infiltration of T cytotoxic lymphocytes and neutrophils in sympathetic ganglia may probably support the idea of possible intracellular infectious pathogen trigger for TAO and consequently infiltration of pathogen-specific T cells into the sympathetic ganglia in TAO.
Keywords: Buerger's disease; inflammation; sympathectomy; sympathetic ganglia; thromboangiitis obliterans.
Conflict of interest statement
Figures


Similar articles
-
Unexpected inflammation in the sympathetic ganglia in thromboangiitis obliterans: more likely sterile or infectious induced inflammation?Clin Mol Allergy. 2019 Jul 6;17:10. doi: 10.1186/s12948-019-0114-2. eCollection 2019. Clin Mol Allergy. 2019. PMID: 31316304 Free PMC article.
-
Skin sympathetic outflow in Buerger's disease.Auton Neurosci. 2001 Mar 23;87(2-3):286-92. doi: 10.1016/S1566-0702(00)00272-1. Auton Neurosci. 2001. PMID: 11476291
-
The role of autoimmunity in thromboangiitis obliterans (Buerger's disease).Ann N Y Acad Sci. 2013 May;1285:15-25. doi: 10.1111/nyas.12048. Epub 2013 Mar 19. Ann N Y Acad Sci. 2013. PMID: 23510296 Review.
-
Integration of traditional Chinese medicine and nibble debridement and dressing method reduces thrombosis and inflammatory response in the treatment of thromboangiitis obliterans.Ann Transl Med. 2021 Sep;9(18):1413. doi: 10.21037/atm-21-3752. Ann Transl Med. 2021. PMID: 34733965 Free PMC article.
-
Thromboangiitis obliterans (Buerger's disease).Vasa. 2014 Sep;43(5):337-46. doi: 10.1024/0301-1526/a000371. Vasa. 2014. PMID: 25147010 Review.
Cited by
-
Unexpected inflammation in the sympathetic ganglia in thromboangiitis obliterans: more likely sterile or infectious induced inflammation?Clin Mol Allergy. 2019 Jul 6;17:10. doi: 10.1186/s12948-019-0114-2. eCollection 2019. Clin Mol Allergy. 2019. PMID: 31316304 Free PMC article.
-
Vaso-nervorumitis: responsible for pain in Buerger's disease?Int Med Case Rep J. 2019 Apr 29;12:119-123. doi: 10.2147/IMCRJ.S197862. eCollection 2019. Int Med Case Rep J. 2019. PMID: 31118831 Free PMC article.
-
Molecular mechanisms regulating immune responses in thromboangiitis obliterans: A comprehensive review.Iran J Basic Med Sci. 2019 Mar;22(3):215-224. doi: 10.22038/ijbms.2019.31119.7513. Iran J Basic Med Sci. 2019. PMID: 31156780 Free PMC article. Review.
-
The Angiography Pattern of Buerger's Disease: Challenges and Recommendations.J Clin Med. 2025 Jul 8;14(14):4841. doi: 10.3390/jcm14144841. J Clin Med. 2025. PMID: 40725544 Free PMC article. Review.
-
The Association of HLA-A, B and DRB1 with Buerger's Disease.Rep Biochem Mol Biol. 2019 Jul;8(2):153-160. Rep Biochem Mol Biol. 2019. PMID: 31832439 Free PMC article.
References
-
- Fazeli B, Ravari H. Mechanisms of thrombosis, available treatments and management challenges presented by thromboangiitis obliterans. Curr Med Chem. 2015;22(16):1992–2001. - PubMed
-
- Olin J W, Shih A. Thromboangiitis obliterans (Buerger's disease) Curr Opin Rheumatol. 2006;18(01):18–24. - PubMed
-
- Fazeli B. Need for changes in clinical criteria for diagnosing Buerger's disease. Vascular. 2013;21(02):117–118. - PubMed
-
- Klein-Weigel P F, Richter J G. Thromboangiitis obliterans (Buerger's disease) Vasa. 2014;43(05):337–346. - PubMed
-
- Olin J W. Thromboangiitis obliterans (Buerger's disease) N Engl J Med. 2000;343(12):864–869. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials